​

Pulse Biosciences Stock (NASDAQ:PLSE)

ForecastOwnershipFinancialsChartTranscripts
Pulse Biosciences by TradingView

Previous Close

$18.25

52W Range

$12.56 - $26.30

50D Avg

$17.21

200D Avg

$16.19

Market Cap

$1.32B

Avg Vol (3M)

$324.33K

Beta

1.82

Div Yield

-

PLSE Company Profile

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

75

IPO Date

May 18, 2016

Website

PLSE Performance

PLSE Financial Summary

Dec 25Dec 24Dec 23
Revenue---
Operating Income$-76.94M$-56.26M$-43.57M
Net Income$-72.78M$-53.59M$-42.21M
EBITDA$-76.94M$-55.08M$-42.37M
Basic EPS$-1.08$-0.92$-0.88
Diluted EPS$-1.08$-0.92$-0.88

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Feb 20, 26 | 4:30 PM
Q3 25Nov 05, 25 | 4:30 PM
Q2 25Aug 12, 25 | 4:30 PM

Peer Comparison

TickerCompany
LFMDLifeMD, Inc.
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.
BBNXBeta Bionics, Inc.
IMTXImmatics N.V.
ATAIAtai Beckley N.V
NKTRNektar Therapeutics
STAASTAAR Surgical Company
OPKOPKO Health, Inc.
NVCRNovoCure Limited
DNTHDianthus Therapeutics, Inc.